42
Participants
Start Date
July 1, 2022
Primary Completion Date
October 30, 2026
Study Completion Date
October 30, 2026
PM8002
IV infusion
nab-paclitaxel
IV infusion
The First Affiliated Hospital of Chongqing Medical University, Chongqing
Affiliated Cancer Hospital of Harbin Medical University, Harbin
Jiangsu Province Hospital, Nanjing
Nanchang Third Hospital, Nanchang
The first ward of breast Surgery, Shandong Cancer Hospital, Jinan
Fudan University Shanghai Cancer Center, Shanghai
Yibin Second People's Hospital, Yibin
Tian Jin Medicial University Cancer Institute&Hospital, Tianjin
Lead Sponsor
Biotheus Inc.
INDUSTRY